Home › NDC Lookup › RxCUI directory › RxCUI 308725

Bexarotene 75 MG Oral Capsule — RxCUI 308725

RxNorm drug concept · Semantic clinical drug
RxCUI 308725 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308725
Official nameBexarotene 75 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)129 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bexarotene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bexarotene is used to treat the skin symptoms of a cancer called cutaneous T-cell lymphoma, or CTCL. It's not a traditional chemotherapy — it's a retinoid, meaning it's related to...
  • What exactly is bexarotene used for — is it a chemotherapy?
  • Bexarotene can affect several important things in your body — your blood fat levels (triglycerides and cholesterol), your liver, your thyroid, and your white blood cell count. Thes...
  • Why do I need so many blood tests while I'm on this medication?
📖 Read our full Bexarotene guide →

🕸️ Concept Web — How Bexarotene 75 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bexarotene 75 MG Oral Capsule RxCUI 308725

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bexarotene 233272
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Targretin 258324
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bexarotene Oral Capsule 379069
    • Bexarotene Oral Product 1161186
    • Bexarotene Pill 1161187
    • Bexarotene Oral Capsule [Targretin] 366557
    • Targretin Oral Product 1179043
    • Targretin Pill 1179044
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bexarotene 75 MG SCDC · 331495
  • Bexarotene Oral Capsule SCDF · 379069
  • Bexarotene Oral Product SCDG · 1161186
  • Bexarotene Pill SCDG · 1161187

Brand-Name Concepts

  • Bexarotene 75 MG Oral Capsule [Targretin] SBD · 261349
  • Bexarotene 75 MG [Targretin] SBDC · 574569
  • Bexarotene Oral Capsule [Targretin] SBDF · 366557
  • Targretin Oral Product SBDG · 1179043
  • Targretin Pill SBDG · 1179044
  • Targretin BN · 258324

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 308725 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-5526-75 1 BOTTLE in 1 CARTON (0187-5526-75) / 100 CAPSULE, LIQUID F... Targretin Bausch Health US, LLC 1999-12-29
00378-6955-01 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0378-6955-0... Bexarotene Mylan Pharmaceuticals Inc. 2015-07-09
00591-2832-01 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01) bexarotene Actavis Pharma, Inc. 2021-11-11
00832-0285-00 100 CAPSULE in 1 BOTTLE (0832-0285-00) Bexarotene Upsher-Smith Laboratories, Inc. 2018-07-25
31722-0380-01 1 BOTTLE in 1 CARTON (31722-380-01) / 100 CAPSULE in 1 BOTT... Bexarotene Camber Pharmaceuticals, Inc. 2025-05-21
42291-0072-01 100 CAPSULE in 1 BOTTLE (42291-072-01) Bexarotene AvKARE 2023-04-14
43975-0315-10 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (43975-315-10) Bexarotene ANI Pharmaceuticals, Inc. 2018-05-10
69238-1250-01 1 BOTTLE in 1 CARTON (69238-1250-1) / 100 CAPSULE in 1 BOTT... Bexarotene Amneal Pharmaceuticals NY LLC 2018-09-04
Observed labelers: Actavis Pharma, Inc. (1) · Amneal Pharmaceuticals NY LLC (1) · ANI Pharmaceuticals, Inc. (1) · AvKARE (1) · Bausch Health US, LLC (1) · Camber Pharmaceuticals, Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.